P Buchwald
University of Miami
H-index: 43
North America-United States
Top articles of P Buchwald
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets | Biomedicines | Jerry Bonnell Oscar Alcazar Brandon Watts Peter Buchwald Midhat H Abdulreda | 2024/2/22 |
A Composite Biomarker Signature of Type 1 Diabetes Risk Identified via Augmentation of Parallel Multi-Omics Data from a Small Cohort | bioRxiv | Oscar Alcazar Sung-Ting Chuang Gang Ren Mitsunori Ogihara Bobbie-Jo M Webb-Robertson | 2024 |
Quantitative receptor model for responses that are left-or right-shifted versus occupancy (are more or less concentration sensitive): the SABRE approach | Frontiers in pharmacology | Peter Buchwald | 2023/12/15 |
Small molecule inhibitors of coronavirus attachment and entry, methods and uses thereof | 2023/11/30 | ||
RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells | Nature communications | Dimitri Van Simaeys Adriana De La Fuente Serena Zilio Alessia Zoso Victoria Kuznetsova | 2022/4/5 |
Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets | Biomolecules | Oscar Alcazar Mitsunori Ogihara Gang Ren Peter Buchwald Midhat H Abdulreda | 2022/10/9 |
Retraction of “Controlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles” | Mehdi Razavi Rosita Primavera Bhavesh D Kevadiya Jing Wang Mujib Ullah | 2022/3/15 | |
Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders | Pharmaceuticals | Sung-Ting Chuang Peter Buchwald | 2022/8/30 |
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19 (preprint) | Sung-Ting Chuang Henrietta Papp Anett Kuczmog Rebecca Eells Jose Manuel Condor Capcha | 2022 | |
Methylene blue is a nonspecific protein–protein interaction inhibitor with potential for repurposing as an antiviral for COVID-19 | Pharmaceuticals | Sung-Ting Chuang Henrietta Papp Anett Kuczmog Rebecca Eells Jose M Condor Capcha | 2022/5/18 |
Parallel evaluation of polyethylene glycol conformal coating and alginate microencapsulation as immunoisolation strategies for pancreatic islet transplantation | Frontiers in bioengineering and biotechnology | Teresa De Toni Aaron A Stock Floriane Devaux Grisell C Gonzalez Kailyn Nunez | 2022/5/16 |
Developing small-molecule inhibitors of protein-protein interactions involved in viral entry as potential antivirals for COVID-19 | Frontiers in Drug Discovery | Peter Buchwald | 2022/4/25 |
Quantification of receptor binding from response data obtained at different receptor levels: a simple individual sigmoid fitting and a unified SABRE approach | Scientific reports | Peter Buchwald | 2022/11/6 |
Methylene blue inhibits the SARS-CoV-2 spike–ACE2 protein-protein interaction–a mechanism that can contribute to its antiviral activity against COVID-19 | Frontiers in pharmacology | Damir Bojadzic Oscar Alcazar Peter Buchwald | 2021 |
Small-molecule inhibitors of the coronavirus spike: ACE2 protein–protein interaction as blockers of viral attachment and entry for SARS-CoV-2 | ACS infectious diseases | Damir Bojadzic Oscar Alcazar Jinshui Chen Sung-Ting Chuang Jose M Condor Capcha | 2021/5/12 |
Drug-Integrating Amphiphilic Nanomaterial Assemblies: 1. Spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils | Journal of controlled release | Diana Velluto Damir Bojadzic Teresa De Toni Peter Buchwald Alice A Tomei | 2021/1/10 |
Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2010‐85) for authorisation of food and feed containing, consisting of and produced from … | EFSA Journal | EFSA Panel on Genetically Modified Organisms (GMO) Hanspeter Naegeli Jean‐Louis Bresson Tamas Dalmay Ian Crawford Dewhurst | 2020/7 |
Parallel multi-omics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes | Biomolecules | Oscar Alcazar Luis F Hernandez Ernesto S Nakayasu Carrie D Nicora Charles Ansong | 2021/3/4 |
Nano-triciribine reduces sars-cov-2 infection by sequestering ace2 and the novel host factor LDLR | Circulation | Jose Manuel Condor Capcha Camila Iansen Irion Guerline Lambert Ahmed Chahdi Peter Buchwald | 2021/11/16 |
Organoid microphysiological system preserves pancreatic islet function within 3D matrix | Science Advances | SN Patel M Ishahak D Chaimov A Velraj D LaShoto | 2021/2/1 |
Co-Authors
